Among the current hypotheses for the treatment of AD, inhibition of acetylcholinesterase enzyme (AChE), which is responsible for the degradation of the neurotransmitter acetylcholine (ACh), is the most widely accepted hypothesis. This evidence concerns the gene ACHE and Alzheimer disease.